CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules

Read the official FDA notice

Published
26 Mar 2025
Units affected
1223 bottles
Agency
FDA
Country
United States

The hazard

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99

Brand / company
Rising Pharma Holding, Inc.
Codes / lots
Lot #: DTB23111A, Exp 8/31/2025
Distribution
Nationwide in the USA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 26 Mar 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.